Fig. 5
From: Immune phenotypes predict survival in patients with glioblastoma multiforme
Kaplan-Meier curves of overall survival and lymphocyte subpopulations, IDH-1 and MGMT mutation status. Overall survival of 51 patients with GBM (a), distinguished by relative amounts of CD expressing lymphocytes. Patients were grouped according to the median values of markers determined by Mann-Whitney U statistical analysis. CD8 cells (b), TCRα/β T cells (c), CD95 expressing lymphocytes (d), CD16/56 activated NK cells (e), and CD127 expressing lymphocytes (f); IDH-1 mutation status (g) and MGMT mutation status (h)